InvestorsHub Logo
Post# of 316461
Next 10
Followers 364
Posts 113767
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Thursday, 10/13/2022 11:26:22 AM

Thursday, October 13, 2022 11:26:22 AM

Post# of 316461
RLMD down 78% experimental treatment for major depressive disorder as a monotherapy did not meet the primary endpoint in a Phase 3 clinical trial.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.